6993.HK — Deck

Blue Moon Group Holdings · 6993.HK · HKEX

Blue Moon Group manufactures and sells household cleaning products in China under a single national brand — #1 in liquid laundry detergent for 16 consecutive years, with gross margins of roughly 60%.

HK$3.13
Price
HK$18.3B
Market cap
HK$8.4B
Revenue (TTM)
59.7%
Gross margin
IPO'd December 2020 at HK$13.16; peaked at HK$18.50 in January 2021; bottomed at HK$1.71 in January 2024; now HK$3.13 — down 76% from IPO price.
2 · The one number

The selling expense ratio is the entire P&L story — and it has been moving in the right direction.

29%
Selling/revenue at IPO (FY2020 — profitable)
70%
H1 2024 peak first net loss in 8 years
53%
Selling/revenue FY2025 full-year loss, but improving
+HK$106M
H2 2025 net income profitable at ~48% ratio

Blue Moon's gross margin has averaged 60% for five consecutive years — the loss is entirely a cost decision made below the gross line. In FY2024, the company spent HK$5.0B on selling against HK$3.4B in manufacturing costs; marketing outran production. When management reduced selling expense to ~48% of revenue in H2 2025, the business earned +HK$106M net income — the operating leverage cuts both ways, and H1 2026 results (expected August 2026) will reveal whether that discipline survives the 618 shopping festival without reverting toward 70%.

3 · Money picture

Reckitt-level gross margins, two consecutive years of net losses, a shrinking cash cushion.

HK$8.4B
Revenue (TTM) flat for 5 years
59.7%
Gross margin (FY2025) 5-yr average ~60%
-HK$329M
Net income FY2025 improved from -HK$749M
HK$3.6B
Net cash (FY2025) 20% of market cap

The 59.7% gross margin matches Reckitt Benckiser globally — from a single-country, single-brand business with four factories in China. Net cash has eroded from HK$9.1B at end-FY2021 to HK$3.6B today, consumed by HK$4.4B in FY2021 shareholder returns and two years of operating losses. At 2.2× P/S, the stock trades at nearly double profitable HKEX consumer peers (Hengan 1.17×, Uni-President 0.88×) — a premium that prices a cost recovery still unproven at full-year scale.

4 · Three pivots, no post-mortems

Blue Moon has abandoned three distribution strategies in six years without explaining any of them to investors.

The IPO bet (2020–2022): Blue Moon raised HK$8.5B in December 2020 with prospectus commitments to build 'Moon House' neighborhood laundry storefronts and expand manufacturing capacity. The storefronts were quietly discontinued by 2022 with no post-mortem disclosure — investors received no accounting of what happened to the capital earmarked for that program.

The Douyin gamble (2023–H1 2024): Management pivoted to live-streaming e-commerce and partnered with mega-influencers at costs that doubled selling expenses year-on-year to HK$5.0B — 70% of H1 2024 revenue. One broadcast distributed 5,000 iPhones to generate a single day's sales. FY2024 produced the first net loss in eight years: HK$749M. When spending was cut in FY2025, revenue fell 1.7% immediately, confirming every sale had been purchased, not earned.

JD.com white knight (March 2026): Blue Moon signed a three-year structured distribution agreement with JD.com targeting RMB 5B (approximately HK$5.3B cumulative) in sales, framing it as a shift to lower-cost structured retail. Of seven major strategic commitments made since the IPO, management delivered on two. This deal is testable: watch H1 2026 selling expense ratio against the 50% threshold.

Management credibility score: 4/10. Every pivot has been labeled 'long-termism.' None has been explained when it ended.
5 · Governance — C−

Founder-chairwoman Pan Dong controls 73.78% and chairs the committee that picks her own overseers.

  • Pan Dong chairs Nominating Committee on 73.78% control. With enough votes to pass every ordinary and special resolution unilaterally, Pan Dong also chairs the Nominating Committee that selects the independent directors whose role is to scrutinize her. All three formal independents serve effectively at her pleasure. The CFO doubles as Company Secretary, concentrating financial reporting and governance administration in one executive.
  • HK$1.05B in dividends paid through two consecutive loss years. Blue Moon distributed HK$0.18/share in FY2025 while reporting a HK$329M net loss — approximately HK$775M flowing to the founding family's stake. The same pattern held in FY2024 (HK$549M dividends during a HK$749M loss). No buyback program exists despite the stock trading 76% below IPO price.
  • Hillhouse Capital's 8.99% is the only institutional counterweight. Zhang Lei's fund has held its stake unchanged since 2010 — through the IPO and the subsequent decline from peak — signaling informed long-term conviction that predates the public listing. It is the one credible check on founding family decision-making outside the formal board structure.
Neither founder has sold a single share since the December 2020 IPO — their loss is real and aligned with public shareholders. But minority shareholders have no mechanism to enforce accountability.
6 · For & against

Lean cautious — the spend-revenue lockstep outweighs the gross margin story until H1 2026 proves otherwise.

  • For. A 60% gross margin sustained for five consecutive years through channel chaos, a HK$749M loss year, and a 76% share-price decline confirms genuine consumer brand power and manufacturing cost advantage — matching Reckitt Benckiser at a fraction of the scale.
  • For. H2 2025 proved the recovery is mechanically accessible: when selling expense fell to ~48% of revenue, the company earned +HK$106M net income in a single half. The operating leverage is real and demonstrable.
  • Against. When Blue Moon cut spending in FY2025, revenue fell 1.7% immediately — the most direct available evidence that no owned customer base exists and every sale must be purchased anew. The JD.com channel has not yet demonstrated it breaks this lockstep.
  • Against. At 2.2× P/S, the stock prices a recovery not yet achieved, at a premium to profitable HKEX peers trading at 0.9–1.2×, with a management team that missed 5 of 7 major strategic commitments and a governance grade of C−.
The gross margin is real; the recovery is not yet proved. The condition that flips the view: H1 2026 results (expected August 2026) printing selling expense below 50% of revenue while revenue grows year-on-year — that combination would disprove the lockstep and change the trade.

Watchlist to re-rate: H1 2026 selling expense ratio vs. 50% threshold (August 2026 results); JD.com-attributed revenue growth alongside promotional cost disclosure; net cash trajectory — whether FY2026 generates positive free cash flow before the next dividend cycle.